2 months Gilead Sciences (NASDAQ:GILD) Upgraded by Leerink Partners to Outperform MarketBeat
Leerink Partners raised Gilead Sciences from a “market perform” rating to an “outperform” rating and raised their price target for the stock from $74.00 to $96.00 in a research note on Monday.
Gilead (GILD) · Nasdaq 100 · Science
X